More on BIIB
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $188.08 |
|
|||
| Open | $186.25 | ||||
| 52 Wk High | $333.65 | ||||
| 52 Wk Low | $223.02 | ||||
| Day High | $186.25 | ||||
| Day Low | $181.24 | ||||
| P/E | 23.67 | ||||
| EPS | $7.81 | ||||
| Volume | 772,902 | ||||
- Biogen to Share New SMA Data at Muscular Dystrophy Association and SMA Europe Conferences
- The New England Journal of Medicine Publishes First Data to Demonstrate the Potential for Disease Modification in Dravet Syndrome
- Stoke Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference
- Barclays launches U.S. biopharma coverage with four preferred picks
- Barclays Starts Biogen (BIIB) at Equalweight
- Form 4 BIOGEN INC. For: Feb 13 Filed by: Viehbacher Christopher
- Form 4 BIOGEN INC. For: Feb 13 Filed by: Singhal Priya
- Form 4 BIOGEN INC. For: Feb 12 Filed by: Murphy Nicole
- Form 4 BIOGEN INC. For: Feb 12 Filed by: Murphy Nicole
- Form 4 BIOGEN INC. For: Feb 13 Filed by: Kramer Robin
Entities mentioned with BIIB
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- ARK | View Related Stories »
- Options | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Maynard Um | View Related Stories »
- Show More...
